Primary Hyperaldosteronism in Japa

Not Applicable

• Conditions: hypertension

• Registration Number: JPRN-UMIN000000998
• Lead Sponsor: ational Hospital Organization

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-02-01
• Study Completion: 2008-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 3500

Inclusion Criteria

Not provided

Exclusion Criteria

1)pregnant patients 2)patients taking diuretics or aldosterone antagonist 3)patients with the following diseases: (1)secondary hypertension (renal hypertension,renovascular hypertension, primary aldosteronism, Cushing's syndrome, pheochromocytoma, iatrogenic diseases etc) (2)patients whom the attending doctors decides not suitable for the entry because of the unstable stage of the following complications: coronary diseases, arrhythmia, severe valvular diseases, cerebrovascular diseases, acute and chronic renal failure (serum Cr higher than 3mg/dl), acute and chronic liver diseases (3)orthostatic hypotension 4) Patients whom the attending doctor decides not suitable for the entry of the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of primary aldosteronism in patients with hypertension in Japan

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are to establish the importance of investigating the cause of hypertension in clinical practice and to spread the standard medical practice specific to the cause of hypertension.